Aktiespot

Sinphar Pharmaceutical Co.,Ltd. (SINPHAR PHARMACEUTICAL CO LTD) Aktie

1734.TW

Geschlossen
$31.45+0.10 (+0.32%)
Chart wird geladen...

SINPHAR PHARMACEUTICAL CO LTD

Eröffnung31.45
Hoch31.55
Tief31.25
Volumen443.47k
P/E16.38
Marktkapitalisierung5.98B
52-Wochen-Hoch32.60
52-Wochen-Tief29.67
Durchschn. Volumen347k
Dividende3.11%
Beta0.14
EPS1.92

Über Sinphar Pharmaceutical Co.,Ltd. (SINPHAR PHARMACEUTICAL CO LTD) Aktie

Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.

Unternehmensinformationen

Börse: Taiwan (TAI)
Sektor: Sundhed
Branche: Bioteknologi
Adresse:
No. 84, Zhongshan Road
269 Yilan City, Taiwan
Telefon: + 886 3 958 1101

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: